MEPSGEN is a biotechnology company that develops human microphysiological system for predictive model of human physiology, and unprecedented microfluidic modules from the lab-scale nanoparticle synthesis to automated large scale GMP manufacturing of lipid nanoparticles encapsulating mRNAs and ASOs.
Dr. YongTae Kim along with Dr. Robert Langer founded the company together in 2019 with their industry leading experience in nanotechnology, drug delivery, and tissue engineering, which is the keystone technology for its microphysiological system products and advanced nanoparticle synthesis. This pioneering technology-based research and development will play a transformative role in the way drug development works into more efficient and scientific direction.
Company Details
- Employees
- 30
- Founded
- -
- Address
- Seoul, Songpa-Gu, Kr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.mepsgen.com
- Keywords
- in bio-convergence research.
- HQ
- Seoul, Songpa-gu
Mepsgen Questions
Mepsgen's website is https://www.mepsgen.com
Mepsgen's LinkedIn profile is https://www.linkedin.com/company/mepsgen
Mepsgen has
30 employees.
View email and phone details for 30
employees at Mepsgen.
Mepsgen's industry is
Biotechnology Research
Mepsgen's top competitors are
Mimetas,
Bia Separations Inc.,
Levitronix,
Indevr, Inc.,
Emulate, Inc.,
Cherry Biotech,
Nagi Bioscience,
Syngoi Technologies,
Linearx, Inc.,
Nucleate.
Mepsgen's categories are Biotechnology Research
Mepsgen's founding year is 2019
